Wells Fargo Starts Pyxis Oncology Inc. (PYXS) at Overweight
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Price: $2.65 --0%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 13 | New: 20
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 13 | New: 20
Join SI Premium – FREE
Wells Fargo initiates coverage on Pyxis Oncology Inc. (NASDAQ: PYXS) with a Overweight rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Pyxis Oncology Inc. click here. For more ratings news on Pyxis Oncology Inc. click here.
Shares of Pyxis Oncology Inc. closed at $2.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Resumes Best Buy (BBY) at Underperform, 'The main risk is we are too early'
- Alliant Energy (LNT) PT Lowered to $75 at Mizuho
- Raymond James Downgrades Alignment Healthcare Inc (ALHC) to Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells Fargo, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
